Shows
The Pharma Marketing PodcastThe Pharma Marketing Podcast - An Interview with John Mack, hosted by R.J. Lewis and Don LangsdorfR.J. Lewis, Founder and CEO and Don Langsdorf, Director of Digital Solutions & Strategy at eHealthcare Solutions interview John Mack, a.k.a. Pharmaguy, the founder of the Pharma Marketing Network. John shares some of his favorite moments from his 20 years as a highly visible and respected maverick in the pharmaceutical and healthcare marketing world. eHealthcare Solutions took over the Pharma Marketing Network from John in 2018, following his retirement, and relaunched pharma-mkting.com in March of 2019.2019-04-1045 min
Pharma TalkThe Misleading Marketing of "Low-T" DrugsA conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses symptom quizzes to convince men and physicians that "low testosterone" is a medical condition that should be treated. We also discuss the dangerous side effects of testosterone treatment and the similarities with estrogen treatment side effects, which took 20 years to unveil.2017-07-2505 min
Pharma TalkThe Forgotten eHealth Code of EthicsAny research or effort designed to improve the quality of health information on the Internet must build upon the work already done by the creators of the international eHealth Code of Ethics, which is as relevant today as it was back in 2000.2017-06-2204 min
Pharma TalkAMA Struggles to Reign in Consumer Drug AdsYou have to give kudos to the good doctors and policy makers of the American Medical Association for trying over the course of many to ban or in some way curtail direct-to-consumer drug ads by pharmaceutical companies. The latest effort focuses on drug price transparency in ads. Will it succeed where the other efforts have failed?2017-06-1504 min
Pharma TalkCounter Detailing Offers Redemption But Little Hope of SuccessDo you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.2017-06-1204 min
Pharma TalkPatient Centricity & Pharma’s ReputationPatient Centricity used to be a buzzword in that it was often mentioned but seldom practiced by pharma companies. A lot of progress has been made in the past years to achieve patient centricity, but not all drug companies have had much success. Unfortunately, that has had a negative impact on the industry’s reputation2017-06-0103 min
Pharma TalkThe Two Faces of FDA Regarding the Opioid EpidemicThe #FDA has a lot of hurdles to overcome in its effort to stem the #opioid crisis it helped to create. And it doesn’t help that Trump’s proposed Medicaid cuts will negatively impact funding for drug rehab treatment.2017-05-2503 min
Pharma TalkThe Coming Digital Transformation of Pharma MarketingMany pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities. Arno Sosna, General Manager of Commercial Products at Veeva , describes efforts that are underway to overcome these inefficiencies and improve communications with physicians.2017-05-1807 min
Pharma TalkBig Pharma Struggles to Distance Itself from “Price Gouging” Small PharmaThe drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic actions2017-05-1204 min
Pharma TalkThe Benefits and Risks of Limiting Pharma Sales Rep Access to PhysiciansPharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.2017-05-0406 min
Pharma TalkThe Digital Gap Between Pharma and Other IndustriesBrain Fox, Senior Partner at McKinsey, talks about how the pharma industry lags other industries in its investment in digital technology and in testing the effectiveness of its digital marketing campaigns.2017-04-2802 min
Pharma TalkThe Internet of Things -> Better Health Outcomes -> Better Adherence -> More ProfitsWhile attending an eyeforpharma Philadelphia conference, Pharmaguy interviewed Jeff Usewick, Director for Healthcare Business Development at SoftServe, about how the drug industry should focus on using Internet of Things technology to improve health outcomes. Better adherence and profits will then follow.2017-04-2402 min
Pharma TalkWhy I March For ScienceThis is the speech I intend to make at the March for Science in Doylestown PA on April 22, 2017.2017-04-2102 min
Pharma TalkDrug Approval Speed Versus Drug SafetyMore user fees paid to the FDA by the drug industry and the push for less rigorous scientific proof in clinical trials may lead to faster drug approvals, but also more deaths due to side effects. Where’s the balance between speed and safety?2017-04-1803 min
Pharma Talk“Patient Centricity” Finally Pays Off for Pharma“Patient Centricity” is finally paying off for drug companies in a BIG way, but it has nothing to do with designing more effective clinical trials or better marketing. It has everything to do with influencing lawmakers and especially the FDA.2017-04-1103 min
Pharma TalkGottlieb's Views on Drug Safety Versus Speed to MarketWhere’s the balance between drug safety and speeding up clinical trials to bring drugs to market faster? That was a major issue underscoring the testimony of Dr. Scott Gottlieb, president Trump’s nominee to head the FDA, before the U.S. Senate Committee on Health, Education, Labor and Pensions.2017-04-0603 min
Pharma TalkWarren Goes After Gottlieb Regarding Drug SafetySenator Elizabeth Warren of Massachusetts challenged Dr. Scott Gottlieb about his views of FDA's drug review process at Gottlieb's April 5, 2017, confirmation hearing before the U.S. Senate Committee on Health, Education, & Pensions.2017-04-0604 min
Pharma TalkDr. Gottlieb's Comments on Opioid EpidemicAt his April 5, 2017, Senate Hearing, Dr. Scott Gottlieb, President Trump's nominee for FDA Commissioner, answered questions about the opioid epidemic by Sen. Tim Kaine, Sen. Michael Bennet, and Sen. Al Franken.2017-04-0508 min
Pharma TalkMaking Sense of DTC Ad Spending: Patients vs TV vs DigitalData about how much money the U.S. pharmaceutical industry spends on promoting drugs to consumers come from several sources, which often report different numbers. That makes it difficult to ferret out what portion of the total is spend on TV and digital, the two most interesting channels.2017-04-0406 min
The Health Crossroad with Dr. Doug Elwood and Dr. Tom Elwood42: John "Pharmaguy" Mack: Inside Look at Pharma Industry From Long-Time ExpertJohn Mack is one of the most well-known voices on the pharmaceutical industry. Known as "pharmaguy" on Twitter, John has several outlets through which he provides "constructive criticism" on the industry, and a wide fan base who follows his insightful commentary. Celebrating 20 years of online writing this year, John has cemented himself as an authority on the industry through podcasts, newsletters, and other venues such as the Pharma Marketing Blog and Pharma Marketing News. In addition to helping us all stay abreast of the industry, John is also an experienced executive with a background in interactive technologies, medical privacy...2014-04-2721 min